MAKERSL177.20

Makers Laboratories Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.72.82.8
+ Finance Costs1.40.90.5
+ Interest Income-0.1-0.1-0.1
+ Dividend Income-0.5-0.0-0.5
Changes in Working Capital
+ Inventories-2.83.2-2.8
+ Trade Receivables — Current0.81.1-0.4
+ Trade Payables — Current5.8-2.01.3
Cash from Operating Activities
Profit Before Tax (per I/S)-7.04.9-2.0
Cash from Operations (pre-tax)-2.7-1.1-1.4
+ Income Taxes Paid0.30.40.6
Cash from Operating Activities-3.1-1.6-2.0
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)2.72.40.3
+ Dividends Received — Investing0.50.00.5
+ Interest Received — Investing0.10.10.0
Cash from Investing Activities-2.016.10.3
Cash from Financing Activities
+ Interest Paid0.90.80.3
Cash from Financing Activities5.1-14.61.7
Net Changes in Cash0.0-0.0-0.0
Reference Items
EBITDA-3.8-2.20.7
EBITDA Margin %-7.66-5.141.45
Free Cash Flow (CFO − Capex)-5.8-4.0-2.3
Free Cash Flow to Equity-18.1-0.2
Cash Flow to Net Income0.441.18
Cash Paid for Taxes0.30.40.6
Cash Paid for Interest0.90.80.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.